Clinicalsummary[1]Todate,thereisnoeffectivetreatmentforirritablebowelsyndrome(IBS-C),whichischaracterizedbysignificantconstipationsymptoms.ProbioticshavebeenrecognizedashavingthepotentialtorelievesymptomsassociatedwithIBS-C.[2]Thepurposeofthisclinicalefficacystudy,conductedbytheMicroCareProbioticsIn

IntroductiontoLactobacillusPlantarumWelcometoourcomprehensiveguideontheroleofLactobacillusPlantaruminguthealth!Ifyou'vebeensearchingforanaturalwaytoimproveyourdigestivesystemandoverallwell-being,looknofurther.LactobacillusPlantarumisheretosavetheday!Withitscountlessbenefitsandeasyincorporationin

AbstractGutdysbiosiscausesdamagetotheintestinalbarrierandisassociatedwithtype2diabetesmellitus(T2DM).WetestedthepotentialprotectiveeffectsofprobioticBL21andLRa05ongutmicrobiotaintype2diabetesmellitusmiceanddeterminedwhethertheseeffectswererelatedtothemodulationofgutmicrobiota.Thirtyspecificpathogen-

Intoday'sfast-pacedworld,digestivediscomforthasbecomeacommoncomplaintamongmanyindividuals.Whetherit'sbloating,gas,orirregularbowelmovements,theseissuescansignificantlyimpactourdailylivesandoverallwell-being.Fortunately,there'sagrowingbodyofevidencesuggestingthatcomplexprobioticscouldoffe

Inagroundbreakingdevelopmentforthefieldofdigestivehealth,recentresearchhasshedlightonthesignificantbenefitsofprobioticsupplementationforadultsexperiencingconstipation.ConductedbyateamofresearchersfromesteemedinstitutionssuchasYanchengThirdPeople'sHospitalandHuazhongUniversityofScienceandTechnolo

Obesityisagrowingglobalhealthconcern,oftenleadingtoseriousconditionssuchashypertension,type2diabetes,andcardiovasculardiseases.Theimbalancebetweenenergyintakeandmetabolismisaprimarycauseofobesity.However,emergingresearchsuggeststhatprobiotics,likeBifidobacteriumlongumsubsp.longumBL21(BL21),canplayac